Staphylococcal infections are difficult to treat due to the rapid emergence of methicillin-resistant staphylococci and, unfortunately, vancomycin-intermediate or -resistant staphylococci. Numerous alternative treatments are urgently required. In this special report, intensive research of new molecules is highlighted--in known antibacterial families and new medicinal chemical entities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1586/14787210.3.4.505 | DOI Listing |
Publication Analysis
Top Keywords
anti-mrsa agents
4
agents investigation
4
investigation exploratory
4
exploratory phase
4
phase clinically
4
clinically staphylococcal
4
staphylococcal infections
4
infections difficult
4
difficult treat
4
treat rapid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!